Trials / Completed
CompletedNCT00100724
Trial of rPA-102 Vaccine in Healthy Adult Volunteers
A Phase 2 Multi-Center, Randomized Dose-Finding Trial of rPA-102 Vaccine in Healthy Adult Volunteers
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 480 (planned)
- Sponsor
- VaxGen · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the safety and immunogenicity of rPA102 vaccine given intramuscularly at 0 and 4 weeks over 2 dose ranges and 4 adjuvant levels.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | rPA102 |
Timeline
- Start date
- 2004-04-01
- Completion
- 2005-07-01
- First posted
- 2005-01-06
- Last updated
- 2006-01-12
Locations
12 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00100724. Inclusion in this directory is not an endorsement.